No Limits

NoLimits is a biotechnology company that leverages advanced artificial intelligence and machine learning to revolutionize protein engineering and drug discovery. The company focuses on designing novel therapeutic proteins and gene delivery vehicles with optimized properties that are beyond the reach of traditional methods. By integrating high-throughput experimental data with generative AI models, NoLimits aims to accelerate the development of treatments for complex and rare diseases. Their platform is designed to overcome significant hurdles in biotherapeutic design, such as stability, specificity, and delivery efficiency.